EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chello, M.
Right arrow Articles by Covino, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chello, M.
Right arrow Articles by Covino, E.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Coronary disease

Eur J Cardiothorac Surg 2001;20:140-146
© 2001 Elsevier Science NL

Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass

M. Chelloa, P. Mastrorobertoa, F. Perticoneb, F. Cirilloa, E. Bevacquaa, S. Olivitoa, E. Covinoa

a Department of Clinical and Experimental Medicine, Division of Cardiac Surgery, University of Catanzaro, Catanzaro, Italy
b Department of Clinical and Experimental Medicine, Division of Cardiology, University of Catanzaro, Catanzaro, Italy

Received 12 October 2000; received in revised form 21 March 2001; accepted 11 April 2001.

Corresponding author. Via S. Giacomo dei Capri 29, 80128 Naples, Italy. Tel.: +39-0961-712309; fax: +39-0961-775337
e-mail: chello{at}unicz.it

Objective: The purpose of this study was to investigate the effectiveness of atrial and brain natriuretic peptides (ANP and BNP, respectively) as indicators of recovery of left ventricular (LV) function after coronary surgery. Methods: We measured the concentrations of these peptides in 31 patients with poor LV function (ejection fraction, EF<35%) undergoing coronary artery bypass, and evaluated their correlation with the echocardiographic indexes of LV function. Results: Pre-operatively, the plasma levels of both ANP and BNP were markedly higher in coronary patients than in normal control subjects, and strongly correlated with both EF (BNP: r=-0.8, P<0.001; ANP: r=-0.6, P<0.001) and wall motion score index (WMSI). At post-operative follow up, plasma levels of both natriuretic peptides were markedly reduced compared with pre-operative values in 21 patients. In addition, the post-operative–pre-operative differences of BNP ({Delta}BNP) and ANP ({Delta}ANP) plasma levels strongly correlated with the differences of both EF (r=-0.7, P<0.0001 vs. {Delta}BNP; r=-0.6, P=0.0003 vs. {Delta}ANP) and WMSI (r=0.6, P=0.002 vs. {Delta}BNP; r=0.6, P=0.04 vs. {Delta}ANP). Finally, by logistic regression analysis, BNP appeared a significant predictor of LVEF recovery after surgery. Conclusion: Plasma levels of ANP and BNP might be used in routine clinical practice as a support to echocardiography in detecting recovery of the LV function after coronary surgery.

Key Words: Atrial natriuretic peptides • Brain natriuretic peptides • Left ventricular dysfunction • Coronary bypass




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. A. Fox, S. K. Shernan, C. D. Collard, K.-Y. Liu, S. F. Aranki, S. M. DeSantis, P. Jarolim, and S. C. Body
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 452 - 461.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Sartipy, A. Albage, P. T. Larsson, P. Insulander, and D. Lindblom
Changes in B-type natriuretic peptides after surgical ventricular restoration
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 922 - 928.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Cannesson, C. Bionda, B. Gostoli, O. Raisky, S. di Filippo, D. Bompard, C. Vedrinne, R. Rousson, J. Ninet, J. Neidecker, et al.
Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation
Anesth. Analg., May 1, 2007; 104(5): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S.-C. Huang, E.-T. Wu, W.-J. Ko, L.-P. Lai, J. Hsu, C.-I. Chang, I.-S. Chiu, S.-S. Wang, M.-H. Wu, F.-Y. Lin, et al.
Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support
Ann. Thorac. Surg., June 1, 2006; 81(6): 2267 - 2272.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Reyes, G. Fores, R. Hugo Rodriguez-Abella, G. Cuerpo, J. L. Vallejo, C. Romero, and A. Pinto
NT-proBNP in cardiac surgery: a new tool for the management of our patients?
Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. Garcia, K. Julier, L. Bestmann, A. Zollinger, L. K. von Segesser, T. Pasch, D. R. Spahn, and M. Zaugg
Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery
Br. J. Anaesth., February 1, 2005; 94(2): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Schenk, P. M. McCarthy, R. C. Starling, K. J. Hoercher, M. D. Hail, Y. Ootaki, G. S. Francis, K. Doi, J. B. Young, and K. Fukamachi
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy
J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 38 - 43.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Georges, F. Forestier, N. Valli, A. Plogin, G. Janvier, and L. Bordenave
Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 941 - 945.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Hutfless, R. Kazanegra, M. Madani, M. A. Bhalla, A. Tulua-Tata, A. Chen, P. Clopton, C. James, A. Chiu, and A. S. Maisel
Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1873 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M.-H. Song, Y. Kobayashi, and H. Michi
Clinical Implication of Atrial and Brain Natriuretic Peptide in Coronary Artery Bypass Grafting
Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Berendes, C. Schmidt, H. Van Aken, M. G. Hartlage, M. Rothenburger, S. Wirtz, H. H. Scheld, G. Brodner, and M. Walter
A-Type and B-Type Natriuretic Peptides in Cardiac Surgical Procedures
Anesth. Analg., January 1, 2004; 98(1): 11 - 19.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.